STAT+: Skylark Bio kicks off new gene therapy trial for deafness
STAT News · LC · trust 28/100
Biotech startups in the U.S., France, and China are racing to bring new gene therapies for deafness by targeting different genetic mutations.
Read the original at STAT News →
Open in TruthVane →